instruction stringlengths 34 186 | input stringlengths 2.02k 93.8k | output stringlengths 2 418 | meta_questiontype stringclasses 6
values | meta_inputlicense stringclasses 6
values | meta_pmid stringlengths 8 8 | meta_safetyreportid int64 9.51M 21M | meta_articlepubdate stringlengths 4 10 |
|---|---|---|---|---|---|---|---|
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Diarrhoea'. | Total neoadjuvant therapy vs standard therapy of locally advanced rectal cancer with high-risk factors for failure.
BACKGROUND
For locally advanced rectal cancer (LARC), standard therapy [consisting of neoadjuvant chemoradiotherapy (CRT), surgery, and adjuvant chemotherapy (ChT)] achieves excellent local control. Unfor... | CAPECITABINE, FLUOROURACIL, LEUCOVORIN, OXALIPLATIN | DrugsGivenReaction | CC BY-NC | 33643528 | 19,024,995 | 2021-02-15 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Embolism'. | Total neoadjuvant therapy vs standard therapy of locally advanced rectal cancer with high-risk factors for failure.
BACKGROUND
For locally advanced rectal cancer (LARC), standard therapy [consisting of neoadjuvant chemoradiotherapy (CRT), surgery, and adjuvant chemotherapy (ChT)] achieves excellent local control. Unfor... | CAPECITABINE, FLUOROURACIL, LEUCOVORIN, OXALIPLATIN | DrugsGivenReaction | CC BY-NC | 33643528 | 19,024,995 | 2021-02-15 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Enterocolitis'. | Total neoadjuvant therapy vs standard therapy of locally advanced rectal cancer with high-risk factors for failure.
BACKGROUND
For locally advanced rectal cancer (LARC), standard therapy [consisting of neoadjuvant chemoradiotherapy (CRT), surgery, and adjuvant chemotherapy (ChT)] achieves excellent local control. Unfor... | CAPECITABINE, FLUOROURACIL, LEUCOVORIN, OXALIPLATIN | DrugsGivenReaction | CC BY-NC | 33643528 | 19,024,995 | 2021-02-15 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hepatotoxicity'. | Total neoadjuvant therapy vs standard therapy of locally advanced rectal cancer with high-risk factors for failure.
BACKGROUND
For locally advanced rectal cancer (LARC), standard therapy [consisting of neoadjuvant chemoradiotherapy (CRT), surgery, and adjuvant chemotherapy (ChT)] achieves excellent local control. Unfor... | CAPECITABINE, FLUOROURACIL, LEUCOVORIN, OXALIPLATIN | DrugsGivenReaction | CC BY-NC | 33643528 | 19,024,995 | 2021-02-15 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Ileus'. | Total neoadjuvant therapy vs standard therapy of locally advanced rectal cancer with high-risk factors for failure.
BACKGROUND
For locally advanced rectal cancer (LARC), standard therapy [consisting of neoadjuvant chemoradiotherapy (CRT), surgery, and adjuvant chemotherapy (ChT)] achieves excellent local control. Unfor... | CAPECITABINE, FLUOROURACIL, LEUCOVORIN, OXALIPLATIN | DrugsGivenReaction | CC BY-NC | 33643528 | 19,024,995 | 2021-02-15 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Infection'. | Total neoadjuvant therapy vs standard therapy of locally advanced rectal cancer with high-risk factors for failure.
BACKGROUND
For locally advanced rectal cancer (LARC), standard therapy [consisting of neoadjuvant chemoradiotherapy (CRT), surgery, and adjuvant chemotherapy (ChT)] achieves excellent local control. Unfor... | CAPECITABINE, FLUOROURACIL, LEUCOVORIN, OXALIPLATIN | DrugsGivenReaction | CC BY-NC | 33643528 | 19,024,995 | 2021-02-15 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Nausea'. | Total neoadjuvant therapy vs standard therapy of locally advanced rectal cancer with high-risk factors for failure.
BACKGROUND
For locally advanced rectal cancer (LARC), standard therapy [consisting of neoadjuvant chemoradiotherapy (CRT), surgery, and adjuvant chemotherapy (ChT)] achieves excellent local control. Unfor... | CAPECITABINE, FLUOROURACIL, LEUCOVORIN, OXALIPLATIN | DrugsGivenReaction | CC BY-NC | 33643528 | 19,024,995 | 2021-02-15 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Neutropenia'. | Total neoadjuvant therapy vs standard therapy of locally advanced rectal cancer with high-risk factors for failure.
BACKGROUND
For locally advanced rectal cancer (LARC), standard therapy [consisting of neoadjuvant chemoradiotherapy (CRT), surgery, and adjuvant chemotherapy (ChT)] achieves excellent local control. Unfor... | CAPECITABINE, FLUOROURACIL, LEUCOVORIN, OXALIPLATIN | DrugsGivenReaction | CC BY-NC | 33643528 | 19,024,995 | 2021-02-15 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Palmar-plantar erythrodysaesthesia syndrome'. | Total neoadjuvant therapy vs standard therapy of locally advanced rectal cancer with high-risk factors for failure.
BACKGROUND
For locally advanced rectal cancer (LARC), standard therapy [consisting of neoadjuvant chemoradiotherapy (CRT), surgery, and adjuvant chemotherapy (ChT)] achieves excellent local control. Unfor... | CAPECITABINE, FLUOROURACIL, LEUCOVORIN, OXALIPLATIN | DrugsGivenReaction | CC BY-NC | 33643528 | 19,024,995 | 2021-02-15 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Paraesthesia'. | Total neoadjuvant therapy vs standard therapy of locally advanced rectal cancer with high-risk factors for failure.
BACKGROUND
For locally advanced rectal cancer (LARC), standard therapy [consisting of neoadjuvant chemoradiotherapy (CRT), surgery, and adjuvant chemotherapy (ChT)] achieves excellent local control. Unfor... | CAPECITABINE, FLUOROURACIL, LEUCOVORIN, OXALIPLATIN | DrugsGivenReaction | CC BY-NC | 33643528 | 19,024,995 | 2021-02-15 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Perineal infection'. | Total neoadjuvant therapy vs standard therapy of locally advanced rectal cancer with high-risk factors for failure.
BACKGROUND
For locally advanced rectal cancer (LARC), standard therapy [consisting of neoadjuvant chemoradiotherapy (CRT), surgery, and adjuvant chemotherapy (ChT)] achieves excellent local control. Unfor... | CAPECITABINE, FLUOROURACIL, LEUCOVORIN, OXALIPLATIN | DrugsGivenReaction | CC BY-NC | 33643528 | 19,024,995 | 2021-02-15 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Stoma site infection'. | Total neoadjuvant therapy vs standard therapy of locally advanced rectal cancer with high-risk factors for failure.
BACKGROUND
For locally advanced rectal cancer (LARC), standard therapy [consisting of neoadjuvant chemoradiotherapy (CRT), surgery, and adjuvant chemotherapy (ChT)] achieves excellent local control. Unfor... | CAPECITABINE, FLUOROURACIL, LEUCOVORIN, OXALIPLATIN | DrugsGivenReaction | CC BY-NC | 33643528 | 19,024,995 | 2021-02-15 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Thrombocytopenia'. | Total neoadjuvant therapy vs standard therapy of locally advanced rectal cancer with high-risk factors for failure.
BACKGROUND
For locally advanced rectal cancer (LARC), standard therapy [consisting of neoadjuvant chemoradiotherapy (CRT), surgery, and adjuvant chemotherapy (ChT)] achieves excellent local control. Unfor... | CAPECITABINE, FLUOROURACIL, LEUCOVORIN, OXALIPLATIN | DrugsGivenReaction | CC BY-NC | 33643528 | 19,024,995 | 2021-02-15 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Vomiting'. | Total neoadjuvant therapy vs standard therapy of locally advanced rectal cancer with high-risk factors for failure.
BACKGROUND
For locally advanced rectal cancer (LARC), standard therapy [consisting of neoadjuvant chemoradiotherapy (CRT), surgery, and adjuvant chemotherapy (ChT)] achieves excellent local control. Unfor... | CAPECITABINE, FLUOROURACIL, LEUCOVORIN, OXALIPLATIN | DrugsGivenReaction | CC BY-NC | 33643528 | 19,024,995 | 2021-02-15 |
What was the administration route of drug 'FLUOROURACIL'? | Total neoadjuvant therapy vs standard therapy of locally advanced rectal cancer with high-risk factors for failure.
BACKGROUND
For locally advanced rectal cancer (LARC), standard therapy [consisting of neoadjuvant chemoradiotherapy (CRT), surgery, and adjuvant chemotherapy (ChT)] achieves excellent local control. Unfor... | Intravenous bolus | DrugAdministrationRoute | CC BY-NC | 33643528 | 19,024,995 | 2021-02-15 |
What was the administration route of drug 'LEUCOVORIN'? | Total neoadjuvant therapy vs standard therapy of locally advanced rectal cancer with high-risk factors for failure.
BACKGROUND
For locally advanced rectal cancer (LARC), standard therapy [consisting of neoadjuvant chemoradiotherapy (CRT), surgery, and adjuvant chemotherapy (ChT)] achieves excellent local control. Unfor... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC | 33643528 | 19,024,995 | 2021-02-15 |
What was the administration route of drug 'OXALIPLATIN'? | Total neoadjuvant therapy vs standard therapy of locally advanced rectal cancer with high-risk factors for failure.
BACKGROUND
For locally advanced rectal cancer (LARC), standard therapy [consisting of neoadjuvant chemoradiotherapy (CRT), surgery, and adjuvant chemotherapy (ChT)] achieves excellent local control. Unfor... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC | 33643528 | 19,024,995 | 2021-02-15 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Motor dysfunction'. | Posterior reversible encephalopathy syndrome presenting as refractory status epilepticus in a patient taking Mycophenolate mofetil for IgA nephropathy: A case report.
•Posterior reversible encephalopathy syndrome is one of the numerous causes of status epilepticus and it should be kept in mind while encountering such c... | MYCOPHENOLATE MOFETIL | DrugsGivenReaction | CC BY-NC-ND | 33643649 | 19,042,858 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Posterior reversible encephalopathy syndrome presenting as refractory status epilepticus in a patient taking Mycophenolate mofetil for IgA nephropathy: A case report.
•Posterior reversible encephalopathy syndrome is one of the numerous causes of status epilepticus and it should be kept in mind while encountering such c... | MYCOPHENOLATE MOFETIL | DrugsGivenReaction | CC BY-NC-ND | 33643649 | 19,018,928 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pneumonia'. | Posterior reversible encephalopathy syndrome presenting as refractory status epilepticus in a patient taking Mycophenolate mofetil for IgA nephropathy: A case report.
•Posterior reversible encephalopathy syndrome is one of the numerous causes of status epilepticus and it should be kept in mind while encountering such c... | MYCOPHENOLATE MOFETIL | DrugsGivenReaction | CC BY-NC-ND | 33643649 | 18,997,351 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Urinary tract infection'. | Posterior reversible encephalopathy syndrome presenting as refractory status epilepticus in a patient taking Mycophenolate mofetil for IgA nephropathy: A case report.
•Posterior reversible encephalopathy syndrome is one of the numerous causes of status epilepticus and it should be kept in mind while encountering such c... | MYCOPHENOLATE MOFETIL | DrugsGivenReaction | CC BY-NC-ND | 33643649 | 18,997,351 | 2021-03 |
What was the outcome of reaction 'Motor dysfunction'? | Posterior reversible encephalopathy syndrome presenting as refractory status epilepticus in a patient taking Mycophenolate mofetil for IgA nephropathy: A case report.
•Posterior reversible encephalopathy syndrome is one of the numerous causes of status epilepticus and it should be kept in mind while encountering such c... | Recovered | ReactionOutcome | CC BY-NC-ND | 33643649 | 19,042,858 | 2021-03 |
What was the outcome of reaction 'Off label use'? | Posterior reversible encephalopathy syndrome presenting as refractory status epilepticus in a patient taking Mycophenolate mofetil for IgA nephropathy: A case report.
•Posterior reversible encephalopathy syndrome is one of the numerous causes of status epilepticus and it should be kept in mind while encountering such c... | Recovered | ReactionOutcome | CC BY-NC-ND | 33643649 | 19,018,928 | 2021-03 |
What was the outcome of reaction 'Pneumonia'? | Posterior reversible encephalopathy syndrome presenting as refractory status epilepticus in a patient taking Mycophenolate mofetil for IgA nephropathy: A case report.
•Posterior reversible encephalopathy syndrome is one of the numerous causes of status epilepticus and it should be kept in mind while encountering such c... | Recovered | ReactionOutcome | CC BY-NC-ND | 33643649 | 18,997,351 | 2021-03 |
What was the outcome of reaction 'Posterior reversible encephalopathy syndrome'? | Posterior reversible encephalopathy syndrome presenting as refractory status epilepticus in a patient taking Mycophenolate mofetil for IgA nephropathy: A case report.
•Posterior reversible encephalopathy syndrome is one of the numerous causes of status epilepticus and it should be kept in mind while encountering such c... | Recovered | ReactionOutcome | CC BY-NC-ND | 33643649 | 19,018,928 | 2021-03 |
What was the outcome of reaction 'Status epilepticus'? | Posterior reversible encephalopathy syndrome presenting as refractory status epilepticus in a patient taking Mycophenolate mofetil for IgA nephropathy: A case report.
•Posterior reversible encephalopathy syndrome is one of the numerous causes of status epilepticus and it should be kept in mind while encountering such c... | Recovered | ReactionOutcome | CC BY-NC-ND | 33643649 | 19,018,928 | 2021-03 |
What was the outcome of reaction 'Urinary tract infection'? | Posterior reversible encephalopathy syndrome presenting as refractory status epilepticus in a patient taking Mycophenolate mofetil for IgA nephropathy: A case report.
•Posterior reversible encephalopathy syndrome is one of the numerous causes of status epilepticus and it should be kept in mind while encountering such c... | Recovered | ReactionOutcome | CC BY-NC-ND | 33643649 | 18,997,351 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Disease complication'. | Carfilzomib-induced pulmonary hypertension with associated right ventricular dysfunction: A case report.
Carfilzomib, a selective proteasome inhibitor, is approved for use in relapsed and refractory multiple myeloma. Its link to left ventricular dysfunction is well established but little is known about its effects on t... | AMLODIPINE BESYLATE, APIXABAN, BENDAMUSTINE, CARFILZOMIB, CARVEDILOL, DEXAMETHASONE | DrugsGivenReaction | CC BY-NC | 33643656 | 19,031,624 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Carfilzomib-induced pulmonary hypertension with associated right ventricular dysfunction: A case report.
Carfilzomib, a selective proteasome inhibitor, is approved for use in relapsed and refractory multiple myeloma. Its link to left ventricular dysfunction is well established but little is known about its effects on t... | AMLODIPINE BESYLATE, APIXABAN, BENDAMUSTINE, CARFILZOMIB, CARVEDILOL, DEXAMETHASONE | DrugsGivenReaction | CC BY-NC | 33643656 | 19,031,624 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Treatment failure'. | Carfilzomib-induced pulmonary hypertension with associated right ventricular dysfunction: A case report.
Carfilzomib, a selective proteasome inhibitor, is approved for use in relapsed and refractory multiple myeloma. Its link to left ventricular dysfunction is well established but little is known about its effects on t... | AMLODIPINE BESYLATE, APIXABAN, BENDAMUSTINE, CARFILZOMIB, CARVEDILOL, DEXAMETHASONE | DrugsGivenReaction | CC BY-NC | 33643656 | 19,031,624 | 2021 |
What was the outcome of reaction 'Disease complication'? | Carfilzomib-induced pulmonary hypertension with associated right ventricular dysfunction: A case report.
Carfilzomib, a selective proteasome inhibitor, is approved for use in relapsed and refractory multiple myeloma. Its link to left ventricular dysfunction is well established but little is known about its effects on t... | Fatal | ReactionOutcome | CC BY-NC | 33643656 | 19,031,624 | 2021 |
What was the outcome of reaction 'Pulmonary hypertension'? | Carfilzomib-induced pulmonary hypertension with associated right ventricular dysfunction: A case report.
Carfilzomib, a selective proteasome inhibitor, is approved for use in relapsed and refractory multiple myeloma. Its link to left ventricular dysfunction is well established but little is known about its effects on t... | Recovered | ReactionOutcome | CC BY-NC | 33643656 | 19,031,624 | 2021 |
What was the administration route of drug 'NOREPINEPHRINE'? | Jarisch-Herxheimer Reaction After Cephalosporin Administration in Syphilis.
The Jarisch-Herxheimer reaction (JHR) is a well-described entity most commonly occurring after the treatment of syphilis with penicillin. Patients often experience flu-like symptoms, in addition to worsening of cutaneous manifestations of syphi... | Intravenous drip | DrugAdministrationRoute | CC BY | 33643725 | 19,002,110 | 2021-01-17 |
What was the dosage of drug 'SODIUM CHLORIDE'? | Jarisch-Herxheimer Reaction After Cephalosporin Administration in Syphilis.
The Jarisch-Herxheimer reaction (JHR) is a well-described entity most commonly occurring after the treatment of syphilis with penicillin. Patients often experience flu-like symptoms, in addition to worsening of cutaneous manifestations of syphi... | 3 LITER | DrugDosageText | CC BY | 33643725 | 19,002,110 | 2021-01-17 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Influenza'. | Immune-related adverse events caused by treatment with pembrolizumab in a patient with lung cancer who infected influenza virus.
A 67-year-old man with stage IV B lung adenocarcinoma was treated with pembrolizumab. The patient was admitted to the hospital because of influenza on the day of the second cycle of pembroliz... | AMLODIPINE BESYLATE, CHONDROITIN SULFATE (BOVINE), CODEINE PHOSPHATE, DEXTROMETHORPHAN HYDROBROMIDE, HYDROCORTISONE BUTYRATE, IPRAGLIFLOZIN L-PROLINE, PEMBROLIZUMAB, SENNOSIDES | DrugsGivenReaction | CC BY-NC-ND | 33643837 | 15,867,611 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Interstitial lung disease'. | Immune-related adverse events caused by treatment with pembrolizumab in a patient with lung cancer who infected influenza virus.
A 67-year-old man with stage IV B lung adenocarcinoma was treated with pembrolizumab. The patient was admitted to the hospital because of influenza on the day of the second cycle of pembroliz... | AMLODIPINE BESYLATE, CHONDROITIN SULFATE (BOVINE), CODEINE PHOSPHATE, DEXTROMETHORPHAN HYDROBROMIDE, HYDROCORTISONE BUTYRATE, IPRAGLIFLOZIN L-PROLINE, PEMBROLIZUMAB, SENNOSIDES | DrugsGivenReaction | CC BY-NC-ND | 33643837 | 15,867,611 | 2021 |
What is the weight of the patient? | Immune-related adverse events caused by treatment with pembrolizumab in a patient with lung cancer who infected influenza virus.
A 67-year-old man with stage IV B lung adenocarcinoma was treated with pembrolizumab. The patient was admitted to the hospital because of influenza on the day of the second cycle of pembroliz... | 68 kg. | Weight | CC BY-NC-ND | 33643837 | 15,867,611 | 2021 |
What was the administration route of drug 'AMLODIPINE BESYLATE'? | Immune-related adverse events caused by treatment with pembrolizumab in a patient with lung cancer who infected influenza virus.
A 67-year-old man with stage IV B lung adenocarcinoma was treated with pembrolizumab. The patient was admitted to the hospital because of influenza on the day of the second cycle of pembroliz... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 33643837 | 15,867,611 | 2021 |
What was the administration route of drug 'CHONDROITIN SULFATE (BOVINE)'? | Immune-related adverse events caused by treatment with pembrolizumab in a patient with lung cancer who infected influenza virus.
A 67-year-old man with stage IV B lung adenocarcinoma was treated with pembrolizumab. The patient was admitted to the hospital because of influenza on the day of the second cycle of pembroliz... | Parenteral | DrugAdministrationRoute | CC BY-NC-ND | 33643837 | 15,867,611 | 2021 |
What was the administration route of drug 'CODEINE PHOSPHATE'? | Immune-related adverse events caused by treatment with pembrolizumab in a patient with lung cancer who infected influenza virus.
A 67-year-old man with stage IV B lung adenocarcinoma was treated with pembrolizumab. The patient was admitted to the hospital because of influenza on the day of the second cycle of pembroliz... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 33643837 | 15,867,611 | 2021 |
What was the administration route of drug 'DEXTROMETHORPHAN HYDROBROMIDE'? | Immune-related adverse events caused by treatment with pembrolizumab in a patient with lung cancer who infected influenza virus.
A 67-year-old man with stage IV B lung adenocarcinoma was treated with pembrolizumab. The patient was admitted to the hospital because of influenza on the day of the second cycle of pembroliz... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 33643837 | 15,867,611 | 2021 |
What was the administration route of drug 'HYDROCORTISONE BUTYRATE'? | Immune-related adverse events caused by treatment with pembrolizumab in a patient with lung cancer who infected influenza virus.
A 67-year-old man with stage IV B lung adenocarcinoma was treated with pembrolizumab. The patient was admitted to the hospital because of influenza on the day of the second cycle of pembroliz... | Parenteral | DrugAdministrationRoute | CC BY-NC-ND | 33643837 | 15,867,611 | 2021 |
What was the administration route of drug 'IPRAGLIFLOZIN L-PROLINE'? | Immune-related adverse events caused by treatment with pembrolizumab in a patient with lung cancer who infected influenza virus.
A 67-year-old man with stage IV B lung adenocarcinoma was treated with pembrolizumab. The patient was admitted to the hospital because of influenza on the day of the second cycle of pembroliz... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 33643837 | 15,867,611 | 2021 |
What was the administration route of drug 'PEMBROLIZUMAB'? | Immune-related adverse events caused by treatment with pembrolizumab in a patient with lung cancer who infected influenza virus.
A 67-year-old man with stage IV B lung adenocarcinoma was treated with pembrolizumab. The patient was admitted to the hospital because of influenza on the day of the second cycle of pembroliz... | Intravenous drip | DrugAdministrationRoute | CC BY-NC-ND | 33643837 | 15,867,611 | 2021 |
What was the administration route of drug 'SENNOSIDES'? | Immune-related adverse events caused by treatment with pembrolizumab in a patient with lung cancer who infected influenza virus.
A 67-year-old man with stage IV B lung adenocarcinoma was treated with pembrolizumab. The patient was admitted to the hospital because of influenza on the day of the second cycle of pembroliz... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 33643837 | 15,867,611 | 2021 |
What was the outcome of reaction 'Influenza'? | Immune-related adverse events caused by treatment with pembrolizumab in a patient with lung cancer who infected influenza virus.
A 67-year-old man with stage IV B lung adenocarcinoma was treated with pembrolizumab. The patient was admitted to the hospital because of influenza on the day of the second cycle of pembroliz... | Recovering | ReactionOutcome | CC BY-NC-ND | 33643837 | 15,867,611 | 2021 |
What was the outcome of reaction 'Interstitial lung disease'? | Immune-related adverse events caused by treatment with pembrolizumab in a patient with lung cancer who infected influenza virus.
A 67-year-old man with stage IV B lung adenocarcinoma was treated with pembrolizumab. The patient was admitted to the hospital because of influenza on the day of the second cycle of pembroliz... | Fatal | ReactionOutcome | CC BY-NC-ND | 33643837 | 15,867,611 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Oxygen therapy via a noninvasive helmet: A COVID-19 novelty with potential post-pandemic uses.
COVID-19 has placed a significant strain upon healthcare resources at a global level and refractory hypoxemia is the leading cause of death among COVID-19 patients. The management of limited resources such as mechanical venti... | HYDROXYCHLOROQUINE, LOPINAVIR\RITONAVIR, OXYGEN, REMDESIVIR, RIBAVIRIN, TOCILIZUMAB | DrugsGivenReaction | CC BY-NC-ND | 33643838 | 19,721,017 | 2021 |
What was the administration route of drug 'OXYGEN'? | Oxygen therapy via a noninvasive helmet: A COVID-19 novelty with potential post-pandemic uses.
COVID-19 has placed a significant strain upon healthcare resources at a global level and refractory hypoxemia is the leading cause of death among COVID-19 patients. The management of limited resources such as mechanical venti... | Nasal | DrugAdministrationRoute | CC BY-NC-ND | 33643838 | 19,721,017 | 2021 |
What was the administration route of drug 'RIBAVIRIN'? | Oxygen therapy via a noninvasive helmet: A COVID-19 novelty with potential post-pandemic uses.
COVID-19 has placed a significant strain upon healthcare resources at a global level and refractory hypoxemia is the leading cause of death among COVID-19 patients. The management of limited resources such as mechanical venti... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 33643838 | 19,721,017 | 2021 |
What was the dosage of drug 'OXYGEN'? | Oxygen therapy via a noninvasive helmet: A COVID-19 novelty with potential post-pandemic uses.
COVID-19 has placed a significant strain upon healthcare resources at a global level and refractory hypoxemia is the leading cause of death among COVID-19 patients. The management of limited resources such as mechanical venti... | 15 LITER /MIN VIA NASAL CANNULA | DrugDosageText | CC BY-NC-ND | 33643838 | 19,721,017 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Anti-neutrophil cytoplasmic antibody positive vasculitis'. | Case Report: Systemic Small-Vessel Vasculitis in an Adolescent With Active Ulcerative Colitis.
Introduction: Small-vessel vasculitis (SVV) is a rare immunological disease that affects arterioles, capillaries and venules. It causes purpura, but can also manifest in other organs, including the gastrointestinal tract. SVV... | AZATHIOPRINE, INFLIXIMAB, MESALAMINE, METHOTREXATE | DrugsGivenReaction | CC BY | 33643972 | 19,016,969 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'C-reactive protein increased'. | Case Report: Systemic Small-Vessel Vasculitis in an Adolescent With Active Ulcerative Colitis.
Introduction: Small-vessel vasculitis (SVV) is a rare immunological disease that affects arterioles, capillaries and venules. It causes purpura, but can also manifest in other organs, including the gastrointestinal tract. SVV... | AZATHIOPRINE, INFLIXIMAB, MESALAMINE, METHOTREXATE | DrugsGivenReaction | CC BY | 33643972 | 19,016,969 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug level below therapeutic'. | Case Report: Systemic Small-Vessel Vasculitis in an Adolescent With Active Ulcerative Colitis.
Introduction: Small-vessel vasculitis (SVV) is a rare immunological disease that affects arterioles, capillaries and venules. It causes purpura, but can also manifest in other organs, including the gastrointestinal tract. SVV... | AZATHIOPRINE, INFLIXIMAB, MESALAMINE, METHOTREXATE | DrugsGivenReaction | CC BY | 33643972 | 19,016,969 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Microscopic polyangiitis'. | Case Report: Systemic Small-Vessel Vasculitis in an Adolescent With Active Ulcerative Colitis.
Introduction: Small-vessel vasculitis (SVV) is a rare immunological disease that affects arterioles, capillaries and venules. It causes purpura, but can also manifest in other organs, including the gastrointestinal tract. SVV... | AZATHIOPRINE, INFLIXIMAB, MESALAMINE, METHOTREXATE | DrugsGivenReaction | CC BY | 33643972 | 19,016,969 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Neuropathy peripheral'. | Case Report: Systemic Small-Vessel Vasculitis in an Adolescent With Active Ulcerative Colitis.
Introduction: Small-vessel vasculitis (SVV) is a rare immunological disease that affects arterioles, capillaries and venules. It causes purpura, but can also manifest in other organs, including the gastrointestinal tract. SVV... | AZATHIOPRINE, INFLIXIMAB, MESALAMINE, METHOTREXATE | DrugsGivenReaction | CC BY | 33643972 | 19,016,969 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Case Report: Systemic Small-Vessel Vasculitis in an Adolescent With Active Ulcerative Colitis.
Introduction: Small-vessel vasculitis (SVV) is a rare immunological disease that affects arterioles, capillaries and venules. It causes purpura, but can also manifest in other organs, including the gastrointestinal tract. SVV... | AZATHIOPRINE, INFLIXIMAB, MESALAMINE, METHOTREXATE | DrugsGivenReaction | CC BY | 33643972 | 19,016,969 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Overdose'. | Case Report: Systemic Small-Vessel Vasculitis in an Adolescent With Active Ulcerative Colitis.
Introduction: Small-vessel vasculitis (SVV) is a rare immunological disease that affects arterioles, capillaries and venules. It causes purpura, but can also manifest in other organs, including the gastrointestinal tract. SVV... | AZATHIOPRINE, INFLIXIMAB, MESALAMINE, METHOTREXATE | DrugsGivenReaction | CC BY | 33643972 | 19,016,969 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Peroneal nerve palsy'. | Case Report: Systemic Small-Vessel Vasculitis in an Adolescent With Active Ulcerative Colitis.
Introduction: Small-vessel vasculitis (SVV) is a rare immunological disease that affects arterioles, capillaries and venules. It causes purpura, but can also manifest in other organs, including the gastrointestinal tract. SVV... | AZATHIOPRINE, INFLIXIMAB, MESALAMINE, METHOTREXATE | DrugsGivenReaction | CC BY | 33643972 | 19,016,969 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Vasculitis'. | Case Report: Systemic Small-Vessel Vasculitis in an Adolescent With Active Ulcerative Colitis.
Introduction: Small-vessel vasculitis (SVV) is a rare immunological disease that affects arterioles, capillaries and venules. It causes purpura, but can also manifest in other organs, including the gastrointestinal tract. SVV... | AZATHIOPRINE, INFLIXIMAB, MESALAMINE, METHOTREXATE | DrugsGivenReaction | CC BY | 33643972 | 19,016,969 | 2021 |
What was the administration route of drug 'INFLIXIMAB'? | Case Report: Systemic Small-Vessel Vasculitis in an Adolescent With Active Ulcerative Colitis.
Introduction: Small-vessel vasculitis (SVV) is a rare immunological disease that affects arterioles, capillaries and venules. It causes purpura, but can also manifest in other organs, including the gastrointestinal tract. SVV... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33643972 | 19,016,969 | 2021 |
What was the administration route of drug 'METHOTREXATE'? | Case Report: Systemic Small-Vessel Vasculitis in an Adolescent With Active Ulcerative Colitis.
Introduction: Small-vessel vasculitis (SVV) is a rare immunological disease that affects arterioles, capillaries and venules. It causes purpura, but can also manifest in other organs, including the gastrointestinal tract. SVV... | Oral | DrugAdministrationRoute | CC BY | 33643972 | 19,016,969 | 2021 |
What was the dosage of drug 'AZATHIOPRINE'? | Case Report: Systemic Small-Vessel Vasculitis in an Adolescent With Active Ulcerative Colitis.
Introduction: Small-vessel vasculitis (SVV) is a rare immunological disease that affects arterioles, capillaries and venules. It causes purpura, but can also manifest in other organs, including the gastrointestinal tract. SVV... | UNKNOWN | DrugDosageText | CC BY | 33643972 | 19,016,969 | 2021 |
What was the dosage of drug 'MESALAMINE'? | Case Report: Systemic Small-Vessel Vasculitis in an Adolescent With Active Ulcerative Colitis.
Introduction: Small-vessel vasculitis (SVV) is a rare immunological disease that affects arterioles, capillaries and venules. It causes purpura, but can also manifest in other organs, including the gastrointestinal tract. SVV... | UNKNOWN | DrugDosageText | CC BY | 33643972 | 19,016,969 | 2021 |
What was the outcome of reaction 'Anti-neutrophil cytoplasmic antibody positive vasculitis'? | Case Report: Systemic Small-Vessel Vasculitis in an Adolescent With Active Ulcerative Colitis.
Introduction: Small-vessel vasculitis (SVV) is a rare immunological disease that affects arterioles, capillaries and venules. It causes purpura, but can also manifest in other organs, including the gastrointestinal tract. SVV... | Recovered with sequelae (consequent health issues) | ReactionOutcome | CC BY | 33643972 | 19,016,969 | 2021 |
What was the outcome of reaction 'C-reactive protein increased'? | Case Report: Systemic Small-Vessel Vasculitis in an Adolescent With Active Ulcerative Colitis.
Introduction: Small-vessel vasculitis (SVV) is a rare immunological disease that affects arterioles, capillaries and venules. It causes purpura, but can also manifest in other organs, including the gastrointestinal tract. SVV... | Recovered | ReactionOutcome | CC BY | 33643972 | 19,016,969 | 2021 |
What was the outcome of reaction 'Drug level below therapeutic'? | Case Report: Systemic Small-Vessel Vasculitis in an Adolescent With Active Ulcerative Colitis.
Introduction: Small-vessel vasculitis (SVV) is a rare immunological disease that affects arterioles, capillaries and venules. It causes purpura, but can also manifest in other organs, including the gastrointestinal tract. SVV... | Recovered | ReactionOutcome | CC BY | 33643972 | 19,016,969 | 2021 |
What was the outcome of reaction 'Neuropathy peripheral'? | Case Report: Systemic Small-Vessel Vasculitis in an Adolescent With Active Ulcerative Colitis.
Introduction: Small-vessel vasculitis (SVV) is a rare immunological disease that affects arterioles, capillaries and venules. It causes purpura, but can also manifest in other organs, including the gastrointestinal tract. SVV... | Not recovered | ReactionOutcome | CC BY | 33643972 | 19,016,969 | 2021 |
What was the outcome of reaction 'Peroneal nerve palsy'? | Case Report: Systemic Small-Vessel Vasculitis in an Adolescent With Active Ulcerative Colitis.
Introduction: Small-vessel vasculitis (SVV) is a rare immunological disease that affects arterioles, capillaries and venules. It causes purpura, but can also manifest in other organs, including the gastrointestinal tract. SVV... | Recovering | ReactionOutcome | CC BY | 33643972 | 19,016,969 | 2021 |
What was the outcome of reaction 'Vasculitis'? | Case Report: Systemic Small-Vessel Vasculitis in an Adolescent With Active Ulcerative Colitis.
Introduction: Small-vessel vasculitis (SVV) is a rare immunological disease that affects arterioles, capillaries and venules. It causes purpura, but can also manifest in other organs, including the gastrointestinal tract. SVV... | Recovered with sequelae (consequent health issues) | ReactionOutcome | CC BY | 33643972 | 19,016,969 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | The Application of Neurodiagnostic Studies to Inform the Acute Management of a Newborn Presenting With Sarbamoyl Shosphate Synthetase 1 Deficiency.
Neonatal-onset urea cycle disorders (UCDs) may result in hyperammonemic (HA) encephalopathy presenting with several neurologic sequelae including seizures, coma, and death.... | FOSPHENYTOIN SODIUM, LEVETIRACETAM, MIDAZOLAM, PHENOBARBITAL | DrugsGivenReaction | CC BY-NC | 33644249 | 19,166,404 | 2021 |
What was the administration route of drug 'LEVETIRACETAM'? | The Application of Neurodiagnostic Studies to Inform the Acute Management of a Newborn Presenting With Sarbamoyl Shosphate Synthetase 1 Deficiency.
Neonatal-onset urea cycle disorders (UCDs) may result in hyperammonemic (HA) encephalopathy presenting with several neurologic sequelae including seizures, coma, and death.... | Oral | DrugAdministrationRoute | CC BY-NC | 33644249 | 19,166,404 | 2021 |
What was the outcome of reaction 'COVID-19'? | Case series: COVID-19 in patients with mild to moderate myasthenia gravis in a National Referral Hospital in Indonesia.
During the COVID-19 pandemic, patients with myasthenia gravis (MG) are most likely to be affected by this situation. Corticosteroids and immunosuppressant agents increase the risk of severe infection.... | Recovered | ReactionOutcome | CC BY-NC-ND | 33644426 | 19,587,759 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Acute myocardial infarction'. | Multiple spontaneous coronary artery dissections associated with intravenous daunorubicin treatment for acute myelocytic leukaemia: a case report.
Multiple spontaneous coronary artery dissection (SCAD) is a rare condition which may lead to serious consequences such as sudden cardiac death, acute myocardial infarction (... | CYTARABINE, DAUNORUBICIN HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC | 33644638 | 19,020,123 | 2021-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cardiogenic shock'. | Multiple spontaneous coronary artery dissections associated with intravenous daunorubicin treatment for acute myelocytic leukaemia: a case report.
Multiple spontaneous coronary artery dissection (SCAD) is a rare condition which may lead to serious consequences such as sudden cardiac death, acute myocardial infarction (... | CYTARABINE, DAUNORUBICIN HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC | 33644638 | 19,020,123 | 2021-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Coronary artery dissection'. | Multiple spontaneous coronary artery dissections associated with intravenous daunorubicin treatment for acute myelocytic leukaemia: a case report.
Multiple spontaneous coronary artery dissection (SCAD) is a rare condition which may lead to serious consequences such as sudden cardiac death, acute myocardial infarction (... | CYTARABINE, DAUNORUBICIN HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC | 33644638 | 19,020,123 | 2021-01 |
What was the administration route of drug 'DAUNORUBICIN HYDROCHLORIDE'? | Multiple spontaneous coronary artery dissections associated with intravenous daunorubicin treatment for acute myelocytic leukaemia: a case report.
Multiple spontaneous coronary artery dissection (SCAD) is a rare condition which may lead to serious consequences such as sudden cardiac death, acute myocardial infarction (... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC | 33644638 | 19,020,123 | 2021-01 |
What was the outcome of reaction 'Acute myocardial infarction'? | Multiple spontaneous coronary artery dissections associated with intravenous daunorubicin treatment for acute myelocytic leukaemia: a case report.
Multiple spontaneous coronary artery dissection (SCAD) is a rare condition which may lead to serious consequences such as sudden cardiac death, acute myocardial infarction (... | Fatal | ReactionOutcome | CC BY-NC | 33644638 | 19,020,123 | 2021-01 |
What was the outcome of reaction 'Cardiogenic shock'? | Multiple spontaneous coronary artery dissections associated with intravenous daunorubicin treatment for acute myelocytic leukaemia: a case report.
Multiple spontaneous coronary artery dissection (SCAD) is a rare condition which may lead to serious consequences such as sudden cardiac death, acute myocardial infarction (... | Fatal | ReactionOutcome | CC BY-NC | 33644638 | 19,020,123 | 2021-01 |
What was the outcome of reaction 'Coronary artery dissection'? | Multiple spontaneous coronary artery dissections associated with intravenous daunorubicin treatment for acute myelocytic leukaemia: a case report.
Multiple spontaneous coronary artery dissection (SCAD) is a rare condition which may lead to serious consequences such as sudden cardiac death, acute myocardial infarction (... | Fatal | ReactionOutcome | CC BY-NC | 33644638 | 19,020,123 | 2021-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cardiac arrest'. | Impact of coronavirus disease 2019 in a child who underwent ventricular septal defect device closure: a case report.
Studies about the incidence and severity of coronavirus disease 2019 (COVID-19) in children are still significantly lower than those in adults. Moreover, data on the effect of COVID-19 in children with c... | AZITHROMYCIN ANHYDROUS, HUMAN IMMUNOGLOBULIN G, HYDROXYCHLOROQUINE, TOCILIZUMAB | DrugsGivenReaction | CC BY-NC | 33644647 | 19,609,750 | 2021-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hypoxia'. | Impact of coronavirus disease 2019 in a child who underwent ventricular septal defect device closure: a case report.
Studies about the incidence and severity of coronavirus disease 2019 (COVID-19) in children are still significantly lower than those in adults. Moreover, data on the effect of COVID-19 in children with c... | AZITHROMYCIN ANHYDROUS, HUMAN IMMUNOGLOBULIN G, HYDROXYCHLOROQUINE, TOCILIZUMAB | DrugsGivenReaction | CC BY-NC | 33644647 | 19,609,750 | 2021-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Multiple organ dysfunction syndrome'. | Impact of coronavirus disease 2019 in a child who underwent ventricular septal defect device closure: a case report.
Studies about the incidence and severity of coronavirus disease 2019 (COVID-19) in children are still significantly lower than those in adults. Moreover, data on the effect of COVID-19 in children with c... | AZITHROMYCIN ANHYDROUS, HUMAN IMMUNOGLOBULIN G, HYDROXYCHLOROQUINE, TOCILIZUMAB | DrugsGivenReaction | CC BY-NC | 33644647 | 19,609,750 | 2021-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Impact of coronavirus disease 2019 in a child who underwent ventricular septal defect device closure: a case report.
Studies about the incidence and severity of coronavirus disease 2019 (COVID-19) in children are still significantly lower than those in adults. Moreover, data on the effect of COVID-19 in children with c... | AZITHROMYCIN ANHYDROUS, HUMAN IMMUNOGLOBULIN G, HYDROXYCHLOROQUINE, TOCILIZUMAB | DrugsGivenReaction | CC BY-NC | 33644647 | 19,609,750 | 2021-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Shock'. | Impact of coronavirus disease 2019 in a child who underwent ventricular septal defect device closure: a case report.
Studies about the incidence and severity of coronavirus disease 2019 (COVID-19) in children are still significantly lower than those in adults. Moreover, data on the effect of COVID-19 in children with c... | AZITHROMYCIN ANHYDROUS, HUMAN IMMUNOGLOBULIN G, HYDROXYCHLOROQUINE, TOCILIZUMAB | DrugsGivenReaction | CC BY-NC | 33644647 | 19,609,750 | 2021-01 |
What is the weight of the patient? | Impact of coronavirus disease 2019 in a child who underwent ventricular septal defect device closure: a case report.
Studies about the incidence and severity of coronavirus disease 2019 (COVID-19) in children are still significantly lower than those in adults. Moreover, data on the effect of COVID-19 in children with c... | 7.1 kg. | Weight | CC BY-NC | 33644647 | 19,609,750 | 2021-01 |
What was the administration route of drug 'HUMAN IMMUNOGLOBULIN G'? | Impact of coronavirus disease 2019 in a child who underwent ventricular septal defect device closure: a case report.
Studies about the incidence and severity of coronavirus disease 2019 (COVID-19) in children are still significantly lower than those in adults. Moreover, data on the effect of COVID-19 in children with c... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC | 33644647 | 19,609,750 | 2021-01 |
What was the dosage of drug 'HUMAN IMMUNOGLOBULIN G'? | Impact of coronavirus disease 2019 in a child who underwent ventricular septal defect device closure: a case report.
Studies about the incidence and severity of coronavirus disease 2019 (COVID-19) in children are still significantly lower than those in adults. Moreover, data on the effect of COVID-19 in children with c... | UNK (TOTAL DOSE OF 2 G/KG) | DrugDosageText | CC BY-NC | 33644647 | 19,609,750 | 2021-01 |
What was the dosage of drug 'TOCILIZUMAB'? | Impact of coronavirus disease 2019 in a child who underwent ventricular septal defect device closure: a case report.
Studies about the incidence and severity of coronavirus disease 2019 (COVID-19) in children are still significantly lower than those in adults. Moreover, data on the effect of COVID-19 in children with c... | 12 MG/KG (REPEATED WITHIN 12 H) | DrugDosageText | CC BY-NC | 33644647 | 19,609,750 | 2021-01 |
What was the outcome of reaction 'Cardiac arrest'? | Impact of coronavirus disease 2019 in a child who underwent ventricular septal defect device closure: a case report.
Studies about the incidence and severity of coronavirus disease 2019 (COVID-19) in children are still significantly lower than those in adults. Moreover, data on the effect of COVID-19 in children with c... | Fatal | ReactionOutcome | CC BY-NC | 33644647 | 19,609,750 | 2021-01 |
What was the outcome of reaction 'Hypoxia'? | Impact of coronavirus disease 2019 in a child who underwent ventricular septal defect device closure: a case report.
Studies about the incidence and severity of coronavirus disease 2019 (COVID-19) in children are still significantly lower than those in adults. Moreover, data on the effect of COVID-19 in children with c... | Fatal | ReactionOutcome | CC BY-NC | 33644647 | 19,609,750 | 2021-01 |
What was the outcome of reaction 'Multiple organ dysfunction syndrome'? | Impact of coronavirus disease 2019 in a child who underwent ventricular septal defect device closure: a case report.
Studies about the incidence and severity of coronavirus disease 2019 (COVID-19) in children are still significantly lower than those in adults. Moreover, data on the effect of COVID-19 in children with c... | Fatal | ReactionOutcome | CC BY-NC | 33644647 | 19,609,750 | 2021-01 |
What was the outcome of reaction 'Shock'? | Impact of coronavirus disease 2019 in a child who underwent ventricular septal defect device closure: a case report.
Studies about the incidence and severity of coronavirus disease 2019 (COVID-19) in children are still significantly lower than those in adults. Moreover, data on the effect of COVID-19 in children with c... | Fatal | ReactionOutcome | CC BY-NC | 33644647 | 19,609,750 | 2021-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cardiac tamponade'. | Hemopericardium with subsequent cardiac tamponade secondary to rivaroxaban treatment: a case report.
The use and utility of novel oral anticoagulants has been increasing in clinical practice due to their relatively lower incidence of side effects such as intracranial haemorrhage, particularly in the elderly, when compa... | RIVAROXABAN | DrugsGivenReaction | CC BY-NC | 33644649 | 18,987,635 | 2021-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pericardial haemorrhage'. | Hemopericardium with subsequent cardiac tamponade secondary to rivaroxaban treatment: a case report.
The use and utility of novel oral anticoagulants has been increasing in clinical practice due to their relatively lower incidence of side effects such as intracranial haemorrhage, particularly in the elderly, when compa... | RIVAROXABAN | DrugsGivenReaction | CC BY-NC | 33644649 | 18,987,635 | 2021-01 |
What was the administration route of drug 'RIVAROXABAN'? | Hemopericardium with subsequent cardiac tamponade secondary to rivaroxaban treatment: a case report.
The use and utility of novel oral anticoagulants has been increasing in clinical practice due to their relatively lower incidence of side effects such as intracranial haemorrhage, particularly in the elderly, when compa... | Oral | DrugAdministrationRoute | CC BY-NC | 33644649 | 18,987,635 | 2021-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Anticoagulation drug level above therapeutic'. | Mechanical valve replacement without anticoagulation: a case report.
For patients who undergo mechanical valve replacement, the greatest disadvantage is that they require long-term or permanent use of anticoagulant therapy to prevent thromboembolism. To date, mechanical valve replacement without anticoagulation has bee... | WARFARIN SODIUM | DrugsGivenReaction | CC BY | 33644653 | 19,008,280 | 2021-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Factor X deficiency'. | Mechanical valve replacement without anticoagulation: a case report.
For patients who undergo mechanical valve replacement, the greatest disadvantage is that they require long-term or permanent use of anticoagulant therapy to prevent thromboembolism. To date, mechanical valve replacement without anticoagulation has bee... | WARFARIN SODIUM | DrugsGivenReaction | CC BY | 33644653 | 19,008,280 | 2021-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Neurological symptom'. | Mechanical valve replacement without anticoagulation: a case report.
For patients who undergo mechanical valve replacement, the greatest disadvantage is that they require long-term or permanent use of anticoagulant therapy to prevent thromboembolism. To date, mechanical valve replacement without anticoagulation has bee... | WARFARIN SODIUM | DrugsGivenReaction | CC BY | 33644653 | 19,008,280 | 2021-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Purpura'. | Mechanical valve replacement without anticoagulation: a case report.
For patients who undergo mechanical valve replacement, the greatest disadvantage is that they require long-term or permanent use of anticoagulant therapy to prevent thromboembolism. To date, mechanical valve replacement without anticoagulation has bee... | WARFARIN SODIUM | DrugsGivenReaction | CC BY | 33644653 | 19,008,280 | 2021-01 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.